Forbes

President Donald Trump told White House OMB director, Russell Vought, to draft an executive order to create a board that would determine which grants the NIH would fund.

NHS hasn’t budgeted for the spending increase entailed by the U.S.-U.K. deal to allow payment for more drugs while keeping funding levels constant for other healthcare.

Sydney Sweeney demonstrated "sploshing' on an episode of the HBO Max series “Euphoria” aired earlier this year. Here's what this sex trend is and precautions to take.

The Trump administration has made bold claims about how much GLOBE and GUARD models will save Medicare. But most of those vanish once the exemptions are accounted for.

From AI-designed drugs to mammography, blood tests and trial matching, a physician describes seven ways AI could speed up cancer cures, and what 2026 data show.

Houston Texans wide receiver Nico Collins, Baltimore Ravens WR Zay Flowers and Seattle Seahawks free safety Tyler Okada will all miss Week 2 due to hamstring injuries.

A doctor answers the most common questions about Legionnaires' disease amid the second outbreak in New York City.

Obesity, type 2 diabetes, fatty liver and heart disease are usually recognized long after a silent process has begun.

By remaining shrouded in mystery, the MFN deals agreed to with drug makers reveal too little to tell how much money they’ll save governments as well as taxpayers and patients.

Longtime ESPN and FOX Sports sidelines sportscaster Erin Andrews was diagnosed with cervical cancer in September 2016. Here's how it's changed her life since.

A doctor cites scientific evidence in fact-checking President Trump's Oval Office address on September 18, 2026 regarding vaccines and autism

Spaceships with tentacles. Designing an award-winning drug. How the Fed hiking rates will impact emerging tech. All that and more in this week’s Prototype.

Philanthropist Melinda French Gates discusses what the findings from a new Gallup-Pivotal survey reveal about the widespread gaps in women’s healthcare and how they impact women’s careers, family life, civic participation and more—and what it will take to build a healthcare system that better serves women throughout their lives.

Medicare costs are set to rise in 2027 as Part D spending accelerates and Medicare Advantage plans prepare major benefit cuts and fraud safeguards lag.